US Patent 9938254 Antiproliferative compounds, and their pharmaceutical compositions and uses
Patent 9938254 was granted and assigned to Celgene on April, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+160 characters)
Article
Patent abstract
Compounds of formula A-I and B-I, compositions comprising the compounds, methods of making the compounds and methods of their uses are disclosed.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
John Sapienza0
Joshua Hansen0
Matthew D. Alexander0
Matthew D. Correa0
Raj Kumar Raheja0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09938254 Antiproliferative compounds, and their pharmaceutical compositions and uses US Patent 9938254 Antiproliferative compounds, and their pharmaceutical compositions and uses
Infobox
Patent Number
099382540
Patent Number
99382540
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099382540
Date of Patent
April 10, 2018
0Patent Application Number
154002080
Date Filed
January 6, 2017
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09938254 Antiproliferative compounds, and their pharmaceutical compositions and uses
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09938254
Date of patent
April 10, 2018
Patent application number
15400208
Date Filed
January 6, 2017
Patent primary examiner
Find more entities like US Patent 9938254 Antiproliferative compounds, and their pharmaceutical compositions and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
